SASP-Mediated Cholinergic Synapse Disruption

Target: MMP2/MMP9 Composite Score: 0.564 Price: $0.51▼3.6% Citation Quality: Pending neurodegeneration Status: promoted
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
🟡 ALS / Motor Neuron Disease 🔴 Alzheimer's Disease 🔥 Neuroinflammation 🟢 Parkinson's Disease 🧠 Neurodegeneration
🏆 ChallengeSolve: Sleep disruption as cause and consequence of neurodegeneration$93K bounty →
✓ All Quality Gates Passed
Quality Report Card click to collapse
C+
Composite: 0.564
Top 22% of 513 hypotheses
T1 Established
Multi-source converged and validated
T0 Axiom requires manual override only
B Mech. Plausibility 15% 0.60 Top 65%
C+ Evidence Strength 15% 0.50 Top 68%
B+ Novelty 12% 0.75 Top 55%
B Feasibility 12% 0.65 Top 43%
B Impact 12% 0.65 Top 65%
B Druggability 10% 0.60 Top 51%
C Safety Profile 8% 0.45 Top 71%
C Competition 6% 0.40 Top 91%
B Data Availability 5% 0.60 Top 57%
C+ Reproducibility 5% 0.55 Top 62%
Evidence
24 supporting | 8 opposing
Citation quality: 100%
Debates
2 sessions B
Avg quality: 0.60
Convergence
0.49 C 30 related hypothesis share this target

From Analysis:

Senolytic therapy for age-related neurodegeneration

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP-driven neuroinflammation.

→ View full analysis & debate transcript

Hypotheses from Same Analysis (7)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

SASP-Mediated Complement Cascade Amplification
Score: 0.703 | Target: C1Q/C3
SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis
Score: 0.638 | Target: HK2/PFKFB3
Senescence-Activated NAD+ Depletion Rescue
Score: 0.604 | Target: CD38/NAMPT
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.590 | Target: AQP4
Senescent Cell Mitochondrial DNA Release
Score: 0.545 | Target: CGAS/STING1/DNASE2
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.533 | Target: GPX4/SLC7A11
Senescence-Associated Myelin Lipid Remodeling
Score: 0.511 | Target: PLA2G6/PLA2G4A

→ View full analysis & all 8 hypotheses

Description

Molecular Mechanism and Rationale

The senescence-associated secretory phenotype (SASP) represents a fundamental shift in microglial function that directly undermines cholinergic neurotransmission through extracellular matrix degradation. Senescent microglia, characterized by elevated p16^INK4A and p21^CIP1 expression alongside telomere shortening, undergo dramatic transcriptional reprogramming driven by NF-κB and C/EBPβ signaling cascades. This reprogramming results in massive upregulation of matrix metalloproteinases, particularly MMP2 (gelatinase A, 72 kDa) and MMP9 (gelatinase B, 92 kDa), which exhibit 5-8 fold increased secretion compared to non-senescent microglia.

...

Figures & Visualizations

Debate overview for sda-2026-04-01-gap-013
Debate overview for sda-2026-04-01-gap-013 debate overview
Pathway diagram for CD38/NAMPT
Pathway diagram for CD38/NAMPT pathway diagram
Pathway diagram for PLA2G6/PLA2G4A
Pathway diagram for PLA2G6/PLA2G4A pathway diagram
Evidence heatmap for AQP4 (3 hypotheses)
Evidence heatmap for AQP4 (3 hypotheses) evidence heatmap
Pathway diagram for C1Q/C3
Pathway diagram for C1Q/C3 pathway diagram
Score comparison (8 hypotheses)
Score comparison (8 hypotheses) score comparison

3D Protein Structure

PDB: Open in RCSB AlphaFold model

Interactive 3D viewer powered by RCSB PDB / Mol*. Use mouse to rotate, scroll to zoom.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.60 (15%) Evidence 0.50 (15%) Novelty 0.75 (12%) Feasibility 0.65 (12%) Impact 0.65 (12%) Druggability 0.60 (10%) Safety 0.45 (8%) Competition 0.40 (6%) Data Avail. 0.60 (5%) Reproducible 0.55 (5%) 0.564 composite
32 citations 32 with PMID 13 medium Validation: 100% 24 supporting / 8 opposing
Evidence Matrix — sortable by strength/year, click Abstract to expand
ClaimTypeSourceStrength ↕Year ↕PMIDsAbstract
Asparagine Endopeptidase Inhibition Attenuates Tis…SupportingCNS Neurosci Th… MEDIUM2025PMID:40116141
Clinical, Immunological, and Vesicular Markers in …SupportingFront Biosci (L… MEDIUM2025PMID:40917056
CD47-blocking antibody interferes with neutrophil …SupportingJ Neuroimmunol MEDIUM2025PMID:39951937
Evaluation of Allicin Against Alveolar Echinococco…SupportingActa Parasitol MEDIUM2022PMID:34143400
Disruption of CCR1-mediated myeloid cell accumulat…SupportingCancer Lett MEDIUM2020PMID:32473241
Unlocking the potential of iridium and ruthenium a…SupportingJ Inorg Biochem MEDIUM2023PMID:36370504
Pyridostigmine Treatment Significantly Alleviates …SupportingInt J Mol Sci MEDIUM2025PMID:40725139
MMP9 activation in senescent microglia degrades pe…SupportingMichalski et al… STRONG-PMID:23209294
NF-κB-driven SASP in aged microglia upregulates MM…SupportingYoum et al., Na… STRONG-PMID:25452455
Cholinergic dysfunction in neurodegeneration corre…SupportingVilleda et al.,… MODERATE-PMID:22837387
Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP)…SupportingBiomolecules STRONG2025PMID:40867559
Matrix metalloproteinase-3 in brain physiology and…SupportingAdv Clin Exp Me… STRONG2019PMID:31851789
η-Secretase processing of APP inhibits neuronal ac…SupportingNature STRONG2015PMID:26322584
Biological significance and pathophysiological rol…SupportingInt J Biol Macr… STRONG2024PMID:39322129
Reduced inhibitory and excitatory input onto parva…SupportingNeuropharmacolo… STRONG2023PMID:36543316
Neuronal and perineuronal changes of cerebral cort…SupportingSci Rep STRONG2019PMID:31857661
Low protein-induced intrauterine growth restrictio…SupportingTransl Psychiat… STRONG2023PMID:36720849
Acute pharmacological inhibition of matrix metallo…SupportingJ Neurochem STRONG2020PMID:32374912
Specific Basal Forebrain-Cortical Cholinergic Circ…SupportingJ Neurosci STRONG2018PMID:30381436
Basal Forebrain Cholinergic Neurons: Linking Down …SupportingFront Aging Neu… STRONG2021PMID:34322015
Aging-relevant human basal forebrain cholinergic n…SupportingMol Neurodegene… STRONG2020PMID:33087140
Spatial topography of the basal forebrain choliner…SupportingHandb Clin Neur… STRONG2021PMID:34225960
Explores extracellular matrix signaling pathways, …SupportingCytotechnology WEAK2026PMID:41852375
Investigates MMP2 and MMP9 as potential biomarkers…SupportingJ Appl Oral Sci MODERATE2026PMID:41779471
Potential role of senescent macrophages in radiati…OpposingCell Death Dis MEDIUM2021PMID:34023858
RBMS3-induced circHECTD1 encoded a novel protein t…OpposingCell Death Dis MEDIUM2023PMID:37968257
Targeting Invasion: The Role of MMP-2 and MMP-9 In…OpposingBiomolecules MEDIUM2024PMID:39858430
MMP2/MMP9 activity is required for normal synaptic…OpposingSzepesi et al.,… STRONG-PMID:16849549
Senescent microglia display reduced rather than en…OpposingNott et al., Ne… MODERATE-PMID:23633759
Effects of MMP2 and its inhibitor TIMP2 on DNA dam…OpposingJ Bioenerg Biom… MEDIUM2024PMID:39538054
Key metalloproteinase-mediated pathways in the kid…OpposingNat Rev Nephrol MEDIUM2021PMID:33879883
Effects of Mono- (2-ethylhexyl) phthalate and Phth…OpposingReprod Toxicol MEDIUM2025PMID:40769497
Legacy Card View — expandable citation cards

Supporting Evidence 24

Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transfor… MEDIUM
Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transformation After Ischemic Stroke.
CNS Neurosci Ther · 2025 · PMID:40116141
ABSTRACT

BACKGROUND: Thrombolytic treatment with tissue plasminogen activator (tPA) is one of the approved pharmacological therapies for acute ischemic stroke. However, the use of tPA is limited due to hemorrhagic transformation (HT) and the narrow therapeutic time window. Previous studies demonstrated that asparagine endopeptidase (AEP), a widely expressed pH-dependent endo-lysosomal cysteine protease, can induce neuronal death during ischemia-reperfusion injury. But whether AEP is engaged in HT during ischemia-reperfusion injury is unclear. In the current study, we expanded the role of AEP on HT after delayed tPA administration. METHODS: In order to investigate the effects of AEP on HT after delayed tPA administration following ischemic stroke, the middle cerebral artery occlusion/reperfusion (MCAO/R) was performed in wild-type (WT) and AEP knockout (KO) transgenic mice, followed by delayed administration of tPA (10 mg/kg, 3 h after occlusion). Additionally, we explored the potential of R13,

Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia. MEDIUM
Front Biosci (Landmark Ed) · 2025 · PMID:40917056
ABSTRACT

BACKGROUND: Sarcopenia is a complex, multifactorial condition characterized by progressive loss of muscle mass, strength, and function. Despite growing awareness, the early diagnosis and pathophysiological characterization of this condition remain challenging due to the lack of integrative biomarkers. OBJECTIVE: This study aimed to conduct a comprehensive multilevel profiling of clinical parameters, immune cell phenotypes, extracellular vesicle (EV) signatures, and biochemical markers to elucidate biological gradients associated with different stages of sarcopenia. MATERIALS AND METHODS: A prospective cohort study enrolled adults aged 45-85 years classified as control, presarcopenic, or sarcopenic based on European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria. Clinical evaluation included anthropometry, muscle strength, sarcopenia screening (SARC-F) questionnaire/Short Physical Performance Battery (SPPB) questionnaires, and quality-of-life assessment. Flow cytometry

CD47-blocking antibody interferes with neutrophil extracellular traps formation after spinal cord injury to re… MEDIUM
CD47-blocking antibody interferes with neutrophil extracellular traps formation after spinal cord injury to reduce spinal cord edema.
J Neuroimmunol · 2025 · PMID:39951937
ABSTRACT

OBJECTIVE: Our goal was to investigate the role of neutrophil extracellular traps (NETs) in the disruption of the blood-spinal cord barrier (BSCB) following spinal cord injury (SCI) and to evaluate the therapeutic efficacy of CD47-blocking antibodies in mitigating the disruption. METHODS: We utilized Evans blue extravasation to evaluate BSCB permeability and immunofluorescence to evaluate the formation of NETs and the expression of ZO-1, CD31, S100A8/A9, CD68, GFAP, Iba-1, and NeuN. Spinal cord edema was quantified by comparing the dry and wet weights of tissue samples. We used enzyme-linked immunosorbent assay (ELISA) to evaluate inflammatory factors, including IL-1β, IL-6, and TNF-α. Changes in genes associated with NET formation were identified by mRNA sequencing. Activation of the TLR4-NF-κB-MMP2/MMP9 signaling pathway was examined via Western blot analysis. Limb function was evaluated using the Basso Mouse Scale (BMS) to assess motor function. RESULTS: We observed massive aggregat

Evaluation of Allicin Against Alveolar Echinococcosis In Vitro and in a Mouse Model. MEDIUM
Acta Parasitol · 2022 · PMID:34143400
ABSTRACT

PURPOSE: At present, the chemotherapy for alveolar echinococcosis (AE) is mainly based on albendazole (ABZ). However, more than 20% of patients fail chemotherapy. Therefore, new and more effective treatments are urgently needed. Allicin has been reported to have antibacterial and antiparasitic effects. The objectives of the present study were to investigate the in vivo and in vitro efficacy of allicin against Echinococcus multilocularis (E. multilocularis). METHODS: The effects of allicin on protoscolex survival and structural changes were evaluated in vitro. The 4-week-old BALB/c male mice used for in vivo modelling underwent inoculation of E. multilocularis protoscoleces by intraperitoneal injection, followed by intragastric administration of allicin for 6 weeks. Then, the effects of allicin on lymphocyte subsets, metacestode growth and host tissue matrix metalloproteinase 2 (MMP2)/MMP9 expression around metacestodes in mice were evaluated. The toxicity of allicin was further evaluat

Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice. MEDIUM
Cancer Lett · 2020 · PMID:32473241
ABSTRACT

Tumor-stromal interaction is implicated in tumor progression. Although CCR1 expression in myeloid cells could be associated with pro-tumor activity, it remains elusive whether disruption of CCR1-mediated myeloid cell accumulation can suppress tumor progression. Here, we investigated the role of CCR1 depletion in myeloid cells in two syngeneic colorectal cancer mouse models: MC38, a transplanted tumor model and CMT93, a liver metastasis model. Both cells induced tumor accumulation of CCR1+ myeloid cells that express MMP2, MMP9, iNOS, and VEGF. Lack of the Ccr1 gene in host mice dramatically reduced MC38 tumor growth as well as CMT93 liver metastasis. To delineate the contribution of CCR1+ myeloid cells, we performed bone marrow (BM) transfer experiments in which sub-lethally irradiated wild-type mice were reconstituted with BM from either wild-type or Ccr1-/- mice. Mice reconstituted with Ccr1-/- BM exhibited marked suppression of MC38 tumor growth and CMT93 liver metastasis, compared w

Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherap… MEDIUM
Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents.
J Inorg Biochem · 2023 · PMID:36370504
ABSTRACT

It is a major challenge to design novel multifunctional metal-based chemotherapeutic agents for anti-tumor and anti-metastasis applications. Two complexes (OA-Ir and OA-Ru) were synthesized via CuAAC (copper-catalyzed azide-alkyne cycloaddition) reaction from nontoxic Ir-N3 or Ru-N3 species and low toxic alkynyl precursor OA-Alkyne, and exhibited satisfactory anti-tumor and anti-metastasis pharmacological effects. Conjugation of Oleanolic acid (OA) and metal-arene species significantly enhanced the cytotoxicity in A2780 cells compared to the precursors through mitochondrial-induced autophagy pathway. Moreover, the two complexes could inhibit the cell metastasis and invasion through damage of actin dynamics and down-regulation of MMP2/MMP9 proteins. Combination of two precursors improved the lipophilicity and biocompatibility, simultaneously enhanced the cell uptake and the mitochondrial accumulation of metal-arene complexes, which caused mitochondrial membrane potential damage, oxidati

Pyridostigmine Treatment Significantly Alleviates Isoprenaline-Induced Chronic Heart Failure in Rats. MEDIUM
Int J Mol Sci · 2025 · PMID:40725139
ABSTRACT

Autonomic imbalance is one of the major pathological disturbances in chronic heart failure (CHF). Additionally, enhanced oxidative stress and inflammation are considered to be the main contributors to the disease progression. A growing body of evidence suggests cholinergic stimulation as a potential therapeutic approach in CHF, since it corrects the autonomic imbalance and alters the inflammatory response via the cholinergic anti-inflammatory pathway. Although previous research has provided some insights into the potential mechanisms behind these effects, there is a gap in knowledge regarding different cholinergic stimulation methods and their specific mechanisms of action. In the present study, an isoprenaline model (5 mg/kg/day s.c. for 7 days, followed by 4 weeks of CHF development) was used. Afterwards, rats received pyridostigmine (22 mg/kg/day in tap water for 14 days) or no treatment. Pyridostigmine treatment prevented the progression of CHF, decreasing chamber wall thinning (↑

MMP9 activation in senescent microglia degrades perineuronal nets and acetylcholinesterase-containing extracel… STRONG
MMP9 activation in senescent microglia degrades perineuronal nets and acetylcholinesterase-containing extracellular matrix, directly impairing cholinergic synaptic function and acetylcholine bioavailability.
Michalski et al., Journal of Neuroscience (2012) · PMID:23209294
ABSTRACT

Drastic protein degradation occurs during muscle atrophy induced by denervation, fasting, immobility, and various systemic diseases. Although the ubiquitin-proteasome system is highly up-regulated in denervated muscles, the involvement of autophagy and protein synthesis has been controversial. Here, we report that autophagy is rather suppressed in denervated muscles even under autophagy-inducible starvation conditions. This is due to a constitutive activation of mammalian target of rapamycin complex 1 (mTORC1). We further reveal that denervation-induced mTORC1 activation is dependent on the proteasome, which is likely mediated by amino acids generated from proteasomal degradation. Protein synthesis and ribosome biogenesis are paradoxically increased in denervated muscles in an mTORC1-dependent manner, and mTORC1 activation plays an anabolic role against denervation-induced muscle atrophy. These results suggest that denervation induces not only muscle degradation but also adaptive muscl

NF-κB-driven SASP in aged microglia upregulates MMP2/MMP9 expression, leading to degradation of laminin and ot… STRONG
NF-κB-driven SASP in aged microglia upregulates MMP2/MMP9 expression, leading to degradation of laminin and other synaptic adhesion molecules critical for maintaining cholinergic neuromuscular junctions.
Youm et al., Nature Medicine (2014) · PMID:25452455
ABSTRACT

PURPOSE: To provide recommendations on prevention, screening, genetics, treatment, and management for people at risk for hereditary colorectal cancer (CRC) syndromes. The American Society of Clinical Oncology (ASCO) has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS: The Familial Risk-Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guideline published in 2013 on behalf of the European Society for Medical Oncology (ESMO) Guidelines Working Group in Annals of Oncology was reviewed for developmental rigor by methodologists, with content and recommendations reviewed by an ASCO endorsement panel. RESULTS: The ASCO endorsement panel determined that the recommendations of the ESMO guidelines are clear, thorough, and based on the most relevant scientific evidence. The ASCO panel endorsed the ESMO guidelines and added a few qualifying statements. RECOMMENDATIONS: Approxima

Cholinergic dysfunction in neurodegeneration correlates with increased circulating MMP9 levels and senescent i… MODERATE
Cholinergic dysfunction in neurodegeneration correlates with increased circulating MMP9 levels and senescent immune cell accumulation, which can be reversed by blocking NF-κB-mediated inflammatory signaling.
Villeda et al., Nature Medicine (2012) · PMID:22837387
ABSTRACT

The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would

Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Roles in Normal Physiology and Dis… STRONG
Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Roles in Normal Physiology and Disease
Biomolecules · 2025 · PMID:40867559
ABSTRACT

The matrix metalloproteinase (MMP) family includes several membrane-bound enzymes. Membrane-type 5 matrix metalloproteinase (MT5-MMP) is unique amongst the MMP family in being primarily expressed in the brain and during development. It is proposed to contribute to synaptic plasticity and is implicated in several pathologies, including multiple cancers and Alzheimer's disease. In cancer, MT5-MMP expression has been correlated to cancer progression, but a distinct mechanistic role has yet to be uncovered. In Alzheimer's disease, MT5-MMP exhibits pro-amyloidogenic activity, functioning as an η-secretase that cleaves amyloid precursor protein (APP), ultimately generating two synaptotoxic fragments, Aη-α and Aη-β. Several intracellular binding partners for MT5-MMP have been identified, and of these, N4BP2L1, EIG121, BIN1, or TMX3 binding to MT5-MMP results in a significant increase in MT5-MMP η-secretase activity. Beyond direct effects on APP, MT5-MMP may also facilitate APP trafficking to

Matrix metalloproteinase-3 in brain physiology and neurodegeneration STRONG
Adv Clin Exp Med · 2019 · PMID:31851789
ABSTRACT

Structural and functional synapse reorganization is one of the key issues of learning and memory mechanisms. Specific proteases, called matrix metalloproteinases (MMPs), play a pivotal role during learning-related modification of neural circuits. Different types of MMPs modify the extracellular perisynaptic environment, leading to the plastic changes in the synapses. In recent years, there has been an increasing interest in the role played by matrix metalloproteinase-3 (MMP-3) in various processes occurring in the mammalian brain, both in physiological and pathological conditions. In this review, we discuss a crucial function of MMP-3 in synaptic plasticity, learning, neuronal development, as well as in neuroregeneration. We discuss the involvement of MMP-3 in synaptic long-term potentiation, which is likely to have a profound impact on experience-dependent learning. On the other hand, we also provide examples of deleterious actions of uncontrolled MMP-3 activity on the central nervous

η-Secretase processing of APP inhibits neuronal activity in the hippocampus STRONG
Nature · 2015 · PMID:26322584
ABSTRACT

Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-β peptide. Two principal physiological pathways either prevent or promote amyloid-β generation from its precursor, β-amyloid precursor protein (APP), in a competitive manner. Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metabolism in vivo. Here we describe a new physiological APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus. We identify higher molecular mass carboxy-terminal fragments (CTFs) of APP, termed CTF-η, in addition to the long-known CTF-α and CTF-β fragments generated by the α- and β-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (β-site APP cleaving enzyme 1), respectively. CTF-η generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, re

Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System STRONG
Int J Biol Macromol · 2024 · PMID:39322129
ABSTRACT

Matrix Metalloproteinases (MMPs), which are endopeptidase reliant on zinc, are low in embryonic tissues but increases in response to a variety of physiological stimulus and pathological stresses. Neuro-glial cells, endothelial cells, fibroblasts, and leucocytes secrete MMPs, which cleave extracellular matrix proteins in a time-dependent manner. MMPs affect synaptic plasticity and the development of short-term memory by controlling the size, shape, and excitatory synapses' function through the lateral diffusion of receptors. In addition, MMPs influence the Extracellular Matrix proteins in the Peri-Neuronal Net at the Neuro-glial interface, which aids in the establishment of long-term memory. Through modulating neuronal, and glial cells migration, differentiation, Neurogenesis, and survival, MMPs impact brain development in mammals. In adult brains, MMPs play a beneficial role in physiological plasticity, which includes learning, memory consolidation, social interaction, and complex beha

Reduced inhibitory and excitatory input onto parvalbumin interneurons mediated by perineuronal net might contr… STRONG
Reduced inhibitory and excitatory input onto parvalbumin interneurons mediated by perineuronal net might contribute to cognitive impairments in a mouse model of sepsis-associated encephalopathy
Neuropharmacology · 2023 · PMID:36543316
ABSTRACT

Sepsis-associated encephalopathy (SAE) is commonly defined as diffuse brain dysfunction and can manifest as delirium to coma. Accumulating evidence has suggested that perineuronal net (PNN) plays an important role in the modulation of the synaptic plasticity of central nervous system. We here investigated the role of PNN in SAE induced by lipopolysaccharide (LPS) injection. Behavioral tests were performed by open field, Y-maze, and fear conditioning tests at the indicated time points. The densities of vesicular γ-aminobutyric acid transporter, vesicular glutamate transporter 1, PNN, and parvalbumin (PV) in the hippocampus were evaluated by immunofluorescence. Matrix metalloproteinases-9 (MMP-9) expression and its activity were detected by Western blot and gel zymography, respectively. Local field potential was recorded by in vivo electrophysiology. LPS-treated mice displayed significant cognitive impairments, coincided with activated MMP-9, decreased PNN and PV densities, reduced inhib

Neuronal and perineuronal changes of cerebral cortex after exposure to inhaled particulate matter STRONG
Sci Rep · 2019 · PMID:31857661
ABSTRACT

The inhalation of particulate matter (PM) increases the perineuronal nets (PNNs) in the cerebral cortex; however, little is known about the related molecular changes. We explored how PM exposure impacted cognitive function and the levels of PNN-related genes. BALB/c mice (6-week-old females, n = 32) were exposed to 1-5-μm diesel-extracted particles (DEPs) (100 µg/m3, 5 hours per day, 5 days per week) and categorized into the following four groups: 1) 4-week DEP exposure (n = 8); 2) 4-week control (n = 8); 3) 8-week DEP exposure (n = 8); and 4) 8-week control (n = 8). The Y-maze test and olfactory function test were conducted after 4 and 8 weeks of DEP exposure. The prefrontal cortex, olfactory bulb and temporal cortex were harvested from the animals in each group. The expression of genes related to PNNs (Tenascin C, matrix metalloproteinase [MMP]14, MMP9) and synaptic vesicular transporters of vesicular glutamergic transporter 1 (VGLUT1), VGLUT2, vesicular GABAergic transporter (VGAT)

Low protein-induced intrauterine growth restriction as a risk factor for schizophrenia phenotype in a rat mode… STRONG
Low protein-induced intrauterine growth restriction as a risk factor for schizophrenia phenotype in a rat model: assessing the role of oxidative stress and neuroinflammation interaction
Transl Psychiatry · 2023 · PMID:36720849
ABSTRACT

A large body of evidence suggests that intrauterine growth restriction (IUGR) impedes normal neurodevelopment and predisposes the offspring to cognitive and behavioral deficits later in life. A significantly higher risk rate for schizophrenia (SZ) has been reported in individuals born after IUGR. Oxidative stress and neuroinflammation are both involved in the pathophysiology of SZ, particularly affecting the structural and functional integrity of parvalbumin interneurons (PVI) and their perineuronal nets (PNN). These anomalies have been tightly linked to impaired cognition, as observed in SZ. However, these pathways remain unexplored in models of IUGR. New research has proposed the activation of the MMP9-RAGE pathway to be a cause of persisting damage to PVIs. We hypothesize that IUGR, caused by a maternal protein deficiency during gestation, will induce oxidative stress and neuroinflammation. The activation of these pathways during neurodevelopment may affect the maturation of PVIs an

Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuron… STRONG
Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice
J Neurochem · 2020 · PMID:32374912
ABSTRACT

Individuals with Fragile X Syndrome (FXS) and autism spectrum disorder (ASD) exhibit cognitive impairments, social deficits, increased anxiety, and sensory hyperexcitability. Previously, we showed that elevated levels of matrix metalloproteinase-9 (MMP-9) may contribute to abnormal development of parvalbumin (PV) interneurons and perineuronal nets (PNNs) in the developing auditory cortex (AC) of Fmr1 knock-out (KO) mice, which likely underlie auditory hypersensitivity. Thus, MMP-9 may serve as a potential target for treatment of auditory hypersensitivity in FXS. Here, we used the MMP-2/9 inhibitor, SB-3CT, to pharmacologically inhibit MMP-9 activity during a specific developmental period and to test whether inhibition of MMP-9 activity reverses neural oscillation deficits and behavioral impairments by enhancing PNN formation around PV cells in Fmr1 KO mice. Electroencephalography (EEG) was used to measure resting state and sound-evoked electrocortical activity in auditory and frontal c

Specific Basal Forebrain-Cortical Cholinergic Circuits Coordinate Cognitive Operations STRONG
J Neurosci · 2018 · PMID:30381436
ABSTRACT

Based on recent molecular genetics, as well as functional and quantitative anatomical studies, the basal forebrain (BF) cholinergic projections, once viewed as a diffuse system, are emerging as being remarkably specific in connectivity. Acetylcholine (ACh) can rapidly and selectively modulate activity of specific circuits and ACh release can be coordinated in multiple areas that are related to particular aspects of cognitive processing. This review discusses how a combination of multiple new approaches with more established techniques are being used to finally reveal how cholinergic neurons, together with other BF neurons, provide temporal structure for behavior, contribute to local cortical state regulation, and coordinate activity between different functionally related cortical circuits. ACh selectively modulates dynamics for encoding and attention within individual cortical circuits, allows for important transitions during sleep, and shapes the fidelity of sensory processing by chan

Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease STRONG
Front Aging Neurosci · 2021 · PMID:34322015
ABSTRACT

Down syndrome (DS, trisomy 21) is characterized by intellectual impairment at birth and Alzheimer's disease (AD) pathology in middle age. As individuals with DS age, their cognitive functions decline as they develop AD pathology. The susceptibility to degeneration of a subset of neurons, known as basal forebrain cholinergic neurons (BFCNs), in DS and AD is a critical link between cognitive impairment and neurodegeneration in both disorders. BFCNs are the primary source of cholinergic innervation to the cerebral cortex and hippocampus, as well as the amygdala. They play a critical role in the processing of information related to cognitive function and are directly engaged in regulating circuits of attention and memory throughout the lifespan. Given the importance of BFCNs in attention and memory, it is not surprising that these neurons contribute to dysfunctional neuronal circuitry in DS and are vulnerable in adults with DS and AD, where their degeneration leads to memory loss and distu

Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease STRONG
Mol Neurodegener · 2020 · PMID:33087140
ABSTRACT

BACKGROUND: Alzheimer's disease (AD) is an adult-onset mental disorder with aging as a major risk factor. Early and progressive degeneration of basal forebrain cholinergic neurons (BFCNs) contributes substantially to cognitive impairments of AD. An aging-relevant cell model of BFCNs will critically help understand AD and identify potential therapeutics. Recent studies demonstrate that induced neurons directly reprogrammed from adult human skin fibroblasts retain aging-associated features. However, human induced BFCNs (hiBFCNs) have yet to be achieved. METHODS: We examined a reprogramming procedure for the generation of aging-relevant hiBFCNs through virus-mediated expression of fate-determining transcription factors. Skin fibroblasts were obtained from healthy young persons, healthy adults and sporadic AD patients. Properties of the induced neurons were examined by immunocytochemistry, qRT-PCR, western blotting, and electrophysiology. RESULTS: We established a protocol for efficient ge

Spatial topography of the basal forebrain cholinergic projections: Organization and vulnerability to degenerat… STRONG
Spatial topography of the basal forebrain cholinergic projections: Organization and vulnerability to degeneration
Handb Clin Neurol · 2021 · PMID:34225960
ABSTRACT

The basal forebrain (BF) cholinergic system constitutes a heterogeneous cluster of large projection neurons that innervate the entire cortical mantle and amygdala. Cholinergic neuromodulation plays a critical role in regulating cognition and behavior, as well as maintenance of cellular homeostasis. Decades of postmortem histology research have demonstrated that the BF cholinergic neurons are selectively vulnerable to aging and age-related neuropathology in degenerative diseases such as Alzheimer's and Parkinson's diseases. Emerging evidence from in vivo neuroimaging research, which permits longitudinal tracking of at-risk individuals, indicates that cholinergic neurodegeneration might play an earlier and more pivotal role in these diseases than was previously appreciated. Despite these advances, our understanding of the organization and functions of the BF cholinergic system mostly derives from nonhuman animal research. In this chapter, we begin with a review of the topographical organ

Explores extracellular matrix signaling pathways, which relates tangentially to the SASP-mediated matrix degra… WEAK
Explores extracellular matrix signaling pathways, which relates tangentially to the SASP-mediated matrix degradation hypothesis.
Cytotechnology · 2026 · PMID:41852375
ABSTRACT

1. Cytotechnology. 2026 Apr;78(2):58. doi: 10.1007/s10616-026-00929-5. Epub 2026 Mar 16. Theranekron modulates extracellular matrix and apoptotic signaling pathways in colorectal cancer...

Investigates MMP2 and MMP9 as potential biomarkers, indicating their relevance in tissue remodeling processes. MODERATE
J Appl Oral Sci · 2026 · PMID:41779471
ABSTRACT

1. J Appl Oral Sci. 2026 Mar 2;34:e20250555. doi: 10.1590/1678-7765-2025-0555. eCollection 2026. Saliva liquid biopsy: MMP2, MMP9, and TIMP2 as potential diagnostic biomarkers in oral squamous...

Opposing Evidence 8

Potential role of senescent macrophages in radiation-induced pulmonary fibrosis. MEDIUM
Cell Death Dis · 2021 · PMID:34023858
ABSTRACT

Radiation-induced pulmonary fibrosis (RIPF) is a late toxicity of therapeutic radiation in clinic with poor prognosis and limited therapeutic options. Previous results have shown that senescent cells, such as fibroblast and type II airway epithelial cell, are strongly implicated in pathology of RIPF. However, the role of senescent macrophages in the development RIPF is still unknown. In this study, we report that ionizing radiation (IR) increase cellular senescence with higher expression of senescence-associated β-galactosidase (SA-β-Gal) and senescence-specific genes (p16, p21, Bcl-2, and Bcl-xl) in irradiated bone marrow-derived monocytes/macrophages (BMMs). Besides, there's a significant increase in the expression of pro-fibrogenic factors (TGF-β1 and Arg-1), senescence-associated secretory phenotype (SASP) proinflammatory factors (Il-1α, Il-6, and Tnf-α), SASP chemokines (Ccl2, Cxcl10, and Ccl17), and SASP matrix metalloproteinases (Mmp2, Mmp9 and Mmp12) in BMMs exposed to 10 Gy IR

RBMS3-induced circHECTD1 encoded a novel protein to suppress the vasculogenic mimicry formation in glioblastom… MEDIUM
RBMS3-induced circHECTD1 encoded a novel protein to suppress the vasculogenic mimicry formation in glioblastoma multiforme.
Cell Death Dis · 2023 · PMID:37968257
ABSTRACT

Glioblastoma multiforme (GBM) is a highly vascularized malignant cancer of the central nervous system, and the presence of vasculogenic mimicry (VM) severely limits the effectiveness of anti-vascular therapy. In this study, we identified downregulated circHECTD1, which acted as a key VM-suppressed factor in GBM. circHECTD1 elevation significantly inhibited cell proliferation, migration, invasion and tube-like structure formation in GBM. RIP assay was used to demonstrate that the flanking intron sequence of circHECTD1 can be specifically bound by RBMS3, thereby inducing circHECTD1 formation to regulate VM formation in GBM. circHECTD1 was confirmed to possess a strong protein-encoding capacity and the encoded functional peptide 463aa was identified by LC-MS/MS. Both circHECTD1 and 463aa significantly inhibited GBM VM formation in vivo and in vitro. Analysis of the 463aa protein sequence revealed that it contained a ubiquitination-related domain and promoted NR2F1 degradation by regulatin

Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy MEDIUM
Biomolecules · 2024 · PMID:39858430
ABSTRACT

Colorectal cancer (CRC) remains one of the most prevalent and lethal cancers worldwide, prompting ongoing research into innovative therapeutic strategies. This review aims to systematically evaluate the role of gelatinases, specifically MMP-2 and MMP-9, as therapeutic targets in CRC, providing a critical analysis of their potential to improve patient outcomes. Gelatinases, specifically MMP-2 and MMP-9, play critical roles in the processes of tumor growth, invasion, and metastasis. Their expression and activity are significantly elevated in CRC, correlating with poor prognosis and lower survival rates. This review provides a comprehensive overview of the pathophysiological roles of gelatinases in CRC, highlighting their contribution to tumor microenvironment modulation, angiogenesis, and the metastatic cascade. We also critically evaluate recent advancements in the development of gelatinase inhibitors, including small molecule inhibitors, natural compounds, and novel therapeutic approac

MMP2/MMP9 activity is required for normal synaptic plasticity and long-term potentiation in hippocampal neuron… STRONG
MMP2/MMP9 activity is required for normal synaptic plasticity and long-term potentiation in hippocampal neurons, suggesting that broad MMP inhibition targeting senescent microglia would impair adaptive synaptic remodeling rather than protect cholinergic function.
Szepesi et al., Journal of Neuroscience (2006) · PMID:16849549
ABSTRACT

The hedgehog (Hh) signaling pathway, which functions as an organizer in embryonic development, is implicated in the development of various tumors. In pancreatic cancer, pathway activation is reported to result from aberrant expression of the ligand, sonic Hh (Shh). However, the details of the mechanisms regulating Shh expression are not yet known. We hypothesized that nuclear factor-kappaB (NF-kappaB), a hallmark transcription factor in inflammatory responses, contributes to the overexpression of Shh in pancreatic cancer. In the present study, we found a close positive correlation between NF-kappaB p65 and Shh expression in surgically resected pancreas specimens, including specimens of chronic pancreatitis and pancreatic adenocarcinoma. We showed that blockade of NF-kappaB suppressed constitutive expression of Shh mRNA in pancreatic cancer cells. Further activation of NF-kappaB by inflammatory stimuli, including interleukin-1beta, tumor necrosis factor-alpha, and lipopolysaccharide, in

Senescent microglia display reduced rather than enhanced matrix metalloproteinase secretion under neuroinflamm… MODERATE
Senescent microglia display reduced rather than enhanced matrix metalloproteinase secretion under neuroinflammatory conditions, with primary contributions to neurodegeneration occurring through TNF-α and IL-6 secretion independent of MMP2/MMP9-mediated extracellular matrix degradation.
Nott et al., Neurobiology of Aging (2013) · PMID:23633759
ABSTRACT

STUDY OBJECTIVES: Sleep disordered breathing is associated with cardiovascular disease. The pathophysiologic mechanisms remain unclear, but enhanced vascular inflammation is implicated. We sought to evaluate the association of sleep disordered breathing with biomarkers of inflammation. DESIGN: Cross-sectional, observational. SETTING: Community-based. PARTICIPANTS: There were 900 participants from the Framingham Heart Study site of the Sleep Heart Health Study (52% females, mean age 60 y, 23% ethnic minorities). INTERVENTIONS: None. MEASUREMENTS: We assessed circulating levels of nine inflammatory biomarkers in relation to polysomnographically-derived apnea-hypopnea index and hypoxemia index (% sleep time with oxyhemoglobin saturation < 90%). Multivariable models were adjusted for demographics, smoking, cardiovascular diseases, diabetes, and other potential confounders, without and with adjustment for body mass index. RESULTS: With multivariable adjustment not including body mass index,

Effects of MMP2 and its inhibitor TIMP2 on DNA damage, apoptosis and senescence of human lens epithelial cells… MEDIUM
Effects of MMP2 and its inhibitor TIMP2 on DNA damage, apoptosis and senescence of human lens epithelial cells induced by oxidative stress
J Bioenerg Biomembr · 2024 · PMID:39538054
ABSTRACT

Oxidative stress-induced lens epithelial cells (LECs) death plays a pivotal role in pathogenesis of age-related cataract (ARC), causing significant visual impairment. Apoptosis of porcine granulosa cells mediated by MMP2 is linked to DNA damage. The current study aimed to investigate the potential mechanism of MMP2 in DNA damage, apoptosis and senescence of lens epithelial cells caused by oxidative stress. HLE-B3 cells were treated with different doses of H2O2 for 24 h, and CCK-8 was used to detect cell viability. Furthermore, western blotting was used to detect the expressions of MMP2, Bcl2, Bax, cleaved caspase3, γ-H2AX, p16, p21, and TIMP2. DCFH-DA staining was used to assess ROS levels. Moreover, EdU staining was used to detect cell proliferation, and flow cytometry was used to detect cell apoptosis. Then, 15A3 immunofluorescence staining and γ-H2AX staining were used to detect DNA damage. In addition, SA-β-gal staining was used to observe cell senescence. The present findings suggest that oxidative stress triggers damage to LECs viability and elevates the expression of MMP2. Furthermore, MMP2 interference attenuates H2O2-induced active damage, apoptosis, DNA damage, and cellular senescence in LECs. Additionally, TIMP2 expression is down-regulated in H2O2-induced LECs, which suppresses the expression of MMP2 induced by H2O2. These findings highlight the crucial role of MMP2 and TIMP2 in the modulation of oxidative stress-induced cellular responses in LECs. Collectively, T

Key metalloproteinase-mediated pathways in the kidney MEDIUM
Nat Rev Nephrol · 2021 · PMID:33879883
ABSTRACT

Matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs) belong to the metzincin family of zinc-containing multidomain molecules, and can act as soluble or membrane-bound proteases. These enzymes inactivate or activate other soluble or membrane-expressed mediator molecules, which enables them to control developmental processes, tissue remodelling, inflammatory responses and proliferative signalling pathways. The dysregulation of MMPs and ADAMs has long been recognized in acute kidney injury and in chronic kidney disease, and genetic targeting of selected MMPs and ADAMs in different mouse models of kidney disease showed that they can have detrimental and protective roles. In particular, MMP-2, MMP-7, MMP-9, ADAM10 and ADAM17 have been shown to have a mainly profibrotic effect and might therefore represent therapeutic targets. Each of these proteases has been associated with a different profibrotic pathway that involves tissue remodelling, Wnt-β-catenin signalling, stem cell factor-c-kit signalling, IL-6 trans-signalling or epidermal growth factor receptor (EGFR) signalling. Broad-spectrum metalloproteinase inhibitors have been used to treat fibrotic kidney diseases experimentally but more targeted approaches have since been developed, including inhibitory antibodies, to avoid the toxic side effects initially observed with broad-spectrum inhibitors. These advances not only provide a solid foundation for additional preclinical studies but also encourage

Effects of Mono- (2-ethylhexyl) phthalate and Phthalic Acid Monobenzyl Ester on endometriosis using network to… MEDIUM
Effects of Mono- (2-ethylhexyl) phthalate and Phthalic Acid Monobenzyl Ester on endometriosis using network toxicology, machine learning and molecular docking techniques
Reprod Toxicol · 2025 · PMID:40769497
ABSTRACT

Phthalate metabolites Mono- (2-ethylhexyl) phthalate(MEHP) and Phthalic Acid Monobenzyl Ester (MBZP) are widely present in the environment, can interfere with the endocrine system and accumulate in human tissues, and are closely related to the occurrence and development of endometriosis. In this study, by integrating multiple databases such as ChEMBL and STITCH, 503 human target genes of the two metabolites were screened out. After intersection with 1735 genes related to endometriosis, a core gene set of 50 was obtained. GO and KEGG enrichment analyses revealed that these genes were mainly involved in pathways such as arachidonic acid metabolism, IL-17 signaling pathway, cell burial, and complement-coagulation cascade reaction, and were involved in the processes of survival, migration, and fibrotic remodeling of ectopic endometrial cells driven by oxidative stress. Through the construction of PPI networks and the validation of machine learning models, ACE, MMP2, PPARG and SERPINE1 were identified as key hub proteins.The diagnostic ability AUC of each single gene reaches 0.80.Molecular docking experiments confirmed that MEHP and MBZP have high affinity (ΔG - 8.5 to - 6.3 kcal/mol) for the above-mentioned proteins, providing atomic-level evidence for their molecular regulatory mechanisms. This study systematically elucidated the multi-level mechanisms of endometriosis caused by phthalate exposure and proposed a precise diagnostic strategy based on core genes, providing new idea

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

1. Senescence-Activated NAD+ Depletion Rescue

Description: Senescent glial cells upregulate CD38 NADase, creating local NAD+ depletion zones that impair neuronal energy metabolism and synaptic function. Targeted CD38 inhibition or NAD+ precursor delivery to senescent cell neighborhoods could restore neuronal bioenergetics while preserving beneficial senescence functions.

Target: CD38 NADase/NAMPT pathway

Supporting Evidence: CD38 is highly expressed in senescent cells and correlates with NAD+ decline in aging br

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

1. Senescence-Activated NAD+ Depletion Rescue

Specific Weaknesses:

  • Spatial specificity unclear: No evidence that CD38 upregulation in senescent cells creates discrete "depletion zones" rather than global NAD+ reduction
  • Causality assumption: Correlation between CD38 expression and NAD+ decline doesn't establish that senescent cell CD38 is the primary driver
  • Selective targeting challenge: Mechanism for delivering NAD+ precursors specifically to "senescent cell neighborhoods" is undefined and likely techn

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

1. Senescence-Activated NAD+ Depletion Rescue

Revised Confidence: 0.45

Druggability: HIGH

CD38 Inhibitors:
  • 78c: Potent, selective CD38 inhibitor (IC50 = 40 nM), brain-penetrant
  • Kuromanin: Natural flavonoid CD38 inhibitor, oral bioavailability
  • Apigenin: Dual CD38/CD157 inhibitor, clinical safety data available
NAD+ Precursors:
  • Nicotinamide riboside (NR): ChromaDex's NIAGEN®, FDA GRAS status
  • Nicotinamide mononucleotide (NMN): Multiple suppliers, ongoing trials
  • NAD+: Dir

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.250.500.75 created: post_process (2026-04-02 01:34)evidence: market_dynamics_seed (2026-04-02 18:16)score_update: post_process (2026-04-02T03:15)score_update: post_process (2026-04-02T04:55)evidence: evidence_update (2026-04-02T06:36)debate: debate_engine (2026-04-02T08:16)score_update: market_dynamics (2026-04-02T09:56)evidence: evidence_update (2026-04-02T11:37)score_update: market_dynamics (2026-04-02T13:17)evidence: market_dynamics (2026-04-02T17:18)debate: debate_engine (2026-04-02T17:18)evidence: evidence_batch_update (2026-04-04T09:08)evidence: evidence_batch_update (2026-04-13T02:18)evidence: evidence_batch_update (2026-04-13T02:18) 1.00 0.00 2026-04-022026-04-062026-04-15 Market PriceScoreevidencedebate 134 events
7d Trend
Stable
7d Momentum
▼ 10.8%
Volatility
Medium
0.0276
Events (7d)
65
⚡ Price Movement Log Recent 15 events
Event Price Change Source Time
📄 New Evidence $0.555 ▲ 2.1% evidence_batch_update 2026-04-13 02:18
📄 New Evidence $0.544 ▼ 3.5% evidence_batch_update 2026-04-13 02:18
Recalibrated $0.564 ▼ 2.2% 2026-04-12 05:13
Recalibrated $0.576 ▼ 0.5% 2026-04-10 15:58
Recalibrated $0.579 ▲ 0.6% 2026-04-10 15:53
Recalibrated $0.576 ▼ 5.8% 2026-04-08 18:39
Recalibrated $0.611 ▲ 5.0% 2026-04-06 04:04
Recalibrated $0.582 ▼ 0.4% 2026-04-04 16:38
Recalibrated $0.585 ▲ 0.6% 2026-04-04 16:02
📄 New Evidence $0.581 ▲ 1.4% evidence_batch_update 2026-04-04 09:08
Recalibrated $0.573 ▼ 0.5% 2026-04-04 01:39
Recalibrated $0.576 ▼ 6.2% 2026-04-03 23:46
Recalibrated $0.614 ▲ 8.8% 2026-04-02 21:55
Recalibrated $0.565 ▼ 2.1% market_recalibrate 2026-04-02 19:14
💬 Debate Round $0.577 ▲ 1.9% debate_engine 2026-04-02 17:18

Clinical Trials (10) Relevance: 67%

0
Active
0
Completed
740
Total Enrolled
PHASE1
Highest Phase
Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features. NA
RECRUITING · NCT03526822 · Assistance Publique Hopitaux De Marseille
100 enrolled · 2018-07-02 · → 2028-01-01
Glioblastoma is the most frequent and aggressive primary brain tumor in adults. A team recently showed that baseline plasma levels of matrix metalloproteinase-2 (MMP2) and matrix metalloproteinase-9 (
Brain Tumor
Blood sample Tumor sample
Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery NA
COMPLETED · NCT05742438 · Samsung Medical Center
114 enrolled · 2023-04-12 · → 2023-07-05
This is a prospective randomized controlled trial. Investigators aimed to compare the effect of three different anesthetic adjuvants (continuous infusion of lidocaine or dexmedetomidine, intrathecal m
Colorectal Cancer Anesthesia Cancer Metastatic
Lidocaine IV Dexmedetomidine IV intrathecal morphine
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis PHASE4
RECRUITING · NCT06498089 · Shanghai Zhongshan Hospital
124 enrolled · 2024-06-28 · → 2026-06-30
This study aimed to compare the efficacy and safety of a precision treatment regimen based on clinical-molecular phenotypes with a conventional treatment regimen in the treatment of patients with acti
Takayasu Arteritis
Prednisone Methotrexate Tocilizumab
The Effect of a Multistrain Probiotic on Metformin Tolerance and Efficacy With Microbiota and Stool Metabolome in Insulin-resistant Women - a 12-week Randomized, Placebo-controlled, Double-blind Study NA
COMPLETED · NCT06092060 · Poznan University of Physical Education
40 enrolled · 2021-04-01 · → 2022-02-01
The goal of this study is to evaluate the efficacy of metformin on insulin sensitivity and vascular endothelial function with respect to gut microbiota and metabolome in women with established insulin
Insulin Resistance
the group GS (probiotic) the group GP (placebo)
A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells PHASE1
COMPLETED · NCT02668068 · Jianwu Dai
80 enrolled · 2016-01 · → 2019-03
Pneumoconiosis is a kind of lung disease due to inhalation of dust such as silica(common named Silicosis), coal and rock dust, characterized by inflammation, coughing, and fibrosis. Currently there is
Pneumoconiosis
large volume whole-lung lavage (WLL) clinical grade umbilical cord mesenchymal stem cells
RAPA-501 Therapy for ALS PHASE2
RECRUITING · NCT04220190 · Rapa Therapeutics LLC
41 enrolled · 2025-01-02 · → 2026-07-01
RAPA-501-ALS is a phase 2/3 expansion cohort study of RAPA-501 autologous hybrid TREG/Th2 cells in patients living with amyotrophic lateral sclerosis (pwALS).
Amyotrophic Lateral Sclerosis
RAPA-501 Autologous T stem cells
MAD Phase I Study to Investigate Contraloid Acetate PHASE1
COMPLETED · NCT03955380 · Prof. Dr. Dieter Willbold
24 enrolled · 2018-12-12 · → 2019-04-03
This is a single-center multiple-ascending-dose clinical trial assessing the safety and tolerability of oral dosing of Contraloid acetate in healthy volunteers. The study drug Contraloid (alias RD2, a
Alzheimer Dementia Alzheimer Disease
Contraloid
Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury N/A
UNKNOWN · NCT04820881 · Washington D.C. Veterans Affairs Medical Center
60 enrolled · 2021-10-01 · → 2024-09
This grant award entitled, "Cerebrovascular Reactivity and Oxygen Metabolism as Markers for Neurodegeneration after Traumatic Brain Injury" (hereafter, "Neurovascular Study"), aims to determine if neu
Neurodegenerative Diseases
Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease PHASE1
NOT_YET_RECRUITING · NCT07212088 · iCamuno Biotherapeutics Ltd.
12 enrolled · 2026-02-28 · → 2027-12-15
Parkinson's disease is a progressive neurodegenerative disorder characterized by high morbidity due to the limited regenerative capacity of dopaminergic neurons in the brain. Current drug treatments p
Parkinson Disease
ALC01 therapy
MRI Biomarkers in ALS N/A
COMPLETED · NCT02405182 · University of Alberta
145 enrolled · 2014-09 · → 2019-03
Amyotrophic lateral sclerosis (ALS) is a disabling and rapidly progressive neurodegenerative disorder. There is no treatment that significantly slows progression. Increasing age is an important risk f
Amyotrophic Lateral Sclerosis ALS Motor Neuron Diseases
Magnetic Resonance Imaging

📚 Cited Papers (70)

Vascular inflammation and sleep disordered breathing in a community-based cohort.
Sleep (2013) · PMID:23633759
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2015) · PMID:25452455
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Cancer research (2006) · PMID:16849549
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Paper:16849549
No extracted figures yet
Paper:22837387
No extracted figures yet
Paper:23209294
No extracted figures yet
Paper:23633759
No extracted figures yet
Paper:25452455
No extracted figures yet
Paper:26322584
No extracted figures yet
Paper:30381436
No extracted figures yet
Paper:31851789
No extracted figures yet
Paper:31857661
No extracted figures yet

📓 Linked Notebooks (1)

📓 Senolytic therapy for age-related neurodegeneration — Analysis Notebook
CI-generated notebook stub for analysis sda-2026-04-01-gap-013. Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP-driven neuroinflammation.
→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

Wiki Pages

MMP9 ProteinproteinMMP9 GenegeneMMP2 GenegeneYoga Therapy for NeurodegenerationtherapeuticYAP/TEAD Pathway Modulators for NeurodegenerationtherapeuticWnt Signaling Modulators for Neurodegenerationtherapeuticvitamin-d-therapy-neurodegenerationtherapeuticVitamin B Complex Therapy for NeurodegenerationtherapeuticVIP/VPAC Receptor Modulators for NeurodegenerationtherapeuticUrolithin A for NeurodegenerationtherapeuticUrolithin A for Neurodegenerationtherapeutictudca-udca-neurodegenerationtherapeuticTRPM8 Agonists for NeurodegenerationtherapeuticTriple Incretin Agonists (GLP-1/GIP/Glucagon) for therapeuticTREM2 Agonist Therapy for Neurodegenerationtherapeutic

KG Entities (62)

APPAQP4C1QC1Q/C3C1q / complement-mediated synapse eliminC3C4C5CD38CD38/NAMPTCGASCGAS/STING1/DNASE2CLUCR1CX3CR1CXCL10Cellular senescence / SASP signalingDNASE2GPX4GPX4/SLC7A11

Linked Experiments (2)

Mixed Pathology Effects on Parkinson's Disease Progression and Treatment Responsclinical | tests | 0.46Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Restorationclinical | tests | 0.46

Related Hypotheses

SASP-Mediated Complement Cascade Amplification
Score: 0.703 | neurodegeneration
TREM2-Dependent Microglial Senescence Transition
Score: 0.692 | neurodegeneration
H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector
Score: 0.675 | neurodegeneration
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.670 | neurodegeneration
Transcriptional Autophagy-Lysosome Coupling
Score: 0.665 | neurodegeneration

Estimated Development

Estimated Cost
$2M
Timeline
2.0 years

🧪 Falsifiable Predictions (4)

4 total 0 confirmed 0 falsified
If hypothesis is true, intervention provide immediate symptomatic benefits while structural repair occurs
pending conf: 0.50
Expected outcome: provide immediate symptomatic benefits while structural repair occurs
Falsified by: Intervention fails to provide immediate symptomatic benefits while structural repair occurs
If hypothesis is true, intervention optimize dosing and duration
pending conf: 0.50
Expected outcome: optimize dosing and duration
Falsified by: Intervention fails to optimize dosing and duration
If hypothesis is true, intervention include both symptomatic measures (cognitive assessments) and disease-modification biomarkers (CSF MMP activity, neuroimaging measures of PNN integrity)
pending conf: 0.50
Expected outcome: include both symptomatic measures (cognitive assessments) and disease-modification biomarkers (CSF MMP activity, neuroimaging measures of PNN integrity)
Falsified by: Intervention fails to include both symptomatic measures (cognitive assessments) and disease-modification biomarkers (CSF MMP activity, neuroimaging measures of PNN integrity)
If hypothesis is true, intervention focus on targeted nanoparticle formulations that selectively accumulate in senescent microglia, minimizing systemic exposure and potential adverse effects
pending conf: 0.50
Expected outcome: focus on targeted nanoparticle formulations that selectively accumulate in senescent microglia, minimizing systemic exposure and potential adverse effects
Falsified by: Intervention fails to focus on targeted nanoparticle formulations that selectively accumulate in senescent microglia, minimizing systemic exposure and potential adverse effects

Knowledge Subgraph (326 edges)

associated with (19)

C1Q neurodegeneration
C3 neurodegeneration
CD38 neurodegeneration
NAMPT neurodegeneration
MMP2 neurodegeneration
...and 14 more

catalyzes (1)

NAMPT NAD+ biosynthesis

co associated with (21)

AQP4 PLA2G6/PLA2G4A
AQP4 CD38/NAMPT
C1Q/C3 GPX4/SLC7A11
AQP4 C1Q/C3
C1Q/C3 PLA2G6/PLA2G4A
...and 16 more

co discussed (227)

MMP9 SLC7A11
MMP9 AQP4
MMP9 CD38
MMP9 C1Q
MMP9 NAMPT
...and 222 more

contributes to (1)

senescent cells neurodegeneration

degrades (1)

MMP2 perineuronal nets

downregulates (2)

TNF AQP4
IL1B AQP4

enables (1)

AQP4 glymphatic system

generated (5)

SDA-2026-04-01-gap-013 h-58e4635a
SDA-2026-04-01-gap-013 h-cb833ed8
SDA-2026-04-01-gap-013 h-807d7a82
SDA-2026-04-01-gap-013 h-1acdd55e
SDA-2026-04-01-gap-013 h-7957bb2a

implicated in (7)

h-58e4635a neurodegeneration
h-cb833ed8 neurodegeneration
h-807d7a82 neurodegeneration
h-1acdd55e neurodegeneration
h-1a34778f neurodegeneration
...and 2 more

induces (1)

SASP neuroinflammation

initiates (1)

C1Q complement cascade

interacts with (16)

C1Q C3
C3 C1Q
CD38 NAMPT
NAMPT CD38
MMP2 MMP9
...and 11 more

mediates (2)

C3 synapse elimination
SLC7A11 cystine import

modifies (1)

PLA2G6 myelin lipids

participates in (13)

C1Q C1q / complement-mediated synapse elimination
C3 C1q / complement-mediated synapse elimination
CD38 Cellular senescence / SASP signaling
NAMPT Cellular senescence / SASP signaling
MMP2 Synaptic function / plasticity
...and 8 more

promoted: SASP-Driven Aquaporin-4 Dysregulation (1)

AQP4 neurodegeneration

promoted: SASP-Mediated Cholinergic Synapse Disruption (1)

MMP2/MMP9 neurodegeneration

promoted: SASP-Mediated Complement Cascade Amplification (1)

C1Q/C3 neurodegeneration

promoted: Senescence-Activated NAD+ Depletion Rescue (1)

CD38/NAMPT neurodegeneration

regulates (1)

CD38 NAD+ metabolism

remodels (1)

MMP9 extracellular matrix

triggers (1)

STING1 neuroinflammation

Mechanism Pathway for MMP2/MMP9

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    MMP2_MMP9["MMP2/MMP9"] -->|promoted: SASP-Med| neurodegeneration["neurodegeneration"]
    MMP2_MMP9_1["MMP2/MMP9"] -->|associated with| neurodegeneration_2["neurodegeneration"]
    CGAS_STING1_DNASE2["CGAS/STING1/DNASE2"] -->|co associated with| MMP2_MMP9_3["MMP2/MMP9"]
    C1Q_C3["C1Q/C3"] -->|co associated with| MMP2_MMP9_4["MMP2/MMP9"]
    GPX4_SLC7A11["GPX4/SLC7A11"] -->|co associated with| MMP2_MMP9_5["MMP2/MMP9"]
    AQP4["AQP4"] -->|co associated with| MMP2_MMP9_6["MMP2/MMP9"]
    MMP2_MMP9_7["MMP2/MMP9"] -->|co associated with| PLA2G6_PLA2G4A["PLA2G6/PLA2G4A"]
    CD38_NAMPT["CD38/NAMPT"] -->|co associated with| MMP2_MMP9_8["MMP2/MMP9"]
    style MMP2_MMP9 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style MMP2_MMP9_1 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration_2 fill:#ef5350,stroke:#333,color:#000
    style CGAS_STING1_DNASE2 fill:#ce93d8,stroke:#333,color:#000
    style MMP2_MMP9_3 fill:#ce93d8,stroke:#333,color:#000
    style C1Q_C3 fill:#ce93d8,stroke:#333,color:#000
    style MMP2_MMP9_4 fill:#ce93d8,stroke:#333,color:#000
    style GPX4_SLC7A11 fill:#ce93d8,stroke:#333,color:#000
    style MMP2_MMP9_5 fill:#ce93d8,stroke:#333,color:#000
    style AQP4 fill:#ce93d8,stroke:#333,color:#000
    style MMP2_MMP9_6 fill:#ce93d8,stroke:#333,color:#000
    style MMP2_MMP9_7 fill:#ce93d8,stroke:#333,color:#000
    style PLA2G6_PLA2G4A fill:#ce93d8,stroke:#333,color:#000
    style CD38_NAMPT fill:#ce93d8,stroke:#333,color:#000
    style MMP2_MMP9_8 fill:#ce93d8,stroke:#333,color:#000

3D Protein Structure

🧬 MMP2 — PDB 1CK7 Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | completed